Do all antihypertensive drugs improve carotid intima-media thickness? A network meta-analysis of randomized controlled trials

Fundamental and Clinical Pharmacology

Volumn 25, Issue 3, 2011, Pages 395-404

  Tropeano, Anne Isabelle ^a   Saleh, Nadine ^a,b,c   Hawajri, Nasser ^b   Macquin Mavier, Isabelle ^a   Maison, Patrick ^a,b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c FACULTÉ DE MÉDECINE   (France)

Author keywords

Antihypertensive; Atherosclerosis; Hypertension; Intima media thickness; Meta analysis

Indexed keywords

AMILORIDE; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CELIPROLOL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; FOSINOPRIL; HYDROCHLOROTHIAZIDE; IRBESARTAN; ISRADIPINE; LACIDIPINE; LISINOPRIL; LOSARTAN; METOPROLOL; NIFEDIPINE; OLMESARTAN; PERINDOPRIL; PLACEBO; QUINAPRIL; RAMIPRIL; TRANDOLAPRIL; UNINDEXED DRUG; VERAPAMIL; ZOFENOPRIL;

ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE REGULATION; DRUG DOSE COMPARISON; DRUG EFFECT; EFFECT SIZE; HUMAN; HYPERTENSION; META ANALYSIS; PLACEBO EFFECT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION;

EID: 79955006821     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00832.x     Document Type: Article

References (57)

1. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Jr Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. (1999) 340 14-22.
2. Hodis H.N., Mack W.J., LaBree L. et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann. Intern. Med. (1998) 128 262-269.
3. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 96 1432-1437.
4. Su T.C., Jeng J.S., Chien K.L., Sung F.C., Hsu H.C., Lee Y.T. Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan. Stroke (2001) 32 2265-2271.
5. Tachibana R., Tabara Y., Kondo I., Miki T., Kohara K. Home blood pressure is a better predictor of carotid atherosclerosis than office blood pressure in community-dwelling subjects. Hypertens. Res. (2004) 27 633-639.
6. Zanchetti A. The antiatherogenic effects of antihypertensive drugs: experimental and clinical evidence. Clin. Exp. Hypertens. A (1992) 14 307-331.
7. Lonn E., Yusuf S., Dzavik V. et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation (2001) 103 919-925.
8. MacMahon S., Sharpe N., Gamble G. et al. Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril. J. Am. Coll. Cardiol. (2000) 36 438-443.
9. Weinstein D.B., Heider J.G. Antiatherogenic properties of calcium antagonists. Am. J. Cardiol. (1987) 59 163B-172B.
10. Bond M.G., Purvis C., Mercuri M. Antiatherogenic properties of calcium antagonists. J. Cardiovasc. Pharmacol. (1991) 17(Suppl 4) S87-S92; discussion S-3.
11. Borhani N.O., Mercuri M., Borhani P.A. et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA (1996) 276 785-791.
12. Wiklund O., Hulthe J., Wikstrand J., Schmidt C., Olofsson S.O., Bondjers G. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke (2002) 33 572-577.
13. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat. Med. (2002) 21 2313-2324.
14. Psaty B.M., Lumley T., Furberg C.D. et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 289 2534-2544.
15. Migdalis I.N., Gerolimou B., Kozanidou G., Hatzigakis S.M., Karmaniolas K.D. Effect of fosinopril sodium on early carotid atherosclerosis in diabetic patients with hypertension. J. Med. (1997) 28 371-380.
16. Roman M.J., Alderman M.H., Pickering T.G. et al. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy. Am. J. Hypertens. (1998) 11 387-396.
17. Zanchetti A., Bond M.G., Hennig M. et al. Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA). J. Hypertens. (2004) 22 1201-1212.
18. Zanchetti A., Rosei E.A., Dal Palu C., Leonetti G., Magnani B., Pessina A. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J. Hypertens. (1998) 16 1667-1676.
19. Koshiyama H., Tanaka S., Minamikawa J. Effect of calcium channel blocker amlodipine on the intimal-medial thickness of carotid arterial wall in type 2 diabetes. J. Cardiovasc. Pharmacol. (1999) 33 894-896.
20. Topouchian J., Asmar R., Sayegh F. et al. Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke (1999) 30 1056-1064.
21. Benetos A., Gautier S., Lafleche A. et al. Blockade of angiotensin II type 1 receptors: effect on carotid and radial artery structure and function in hypertensive humans. J. Vasc. Res. (2000) 37 8-15; discussion 68-70.
22. Boutouyrie P., Bussy C., Hayoz D. et al. Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation (2000) 101 2601-2606.
23. Hedblad B., Wikstrand J., Janzon L., Wedel H., Berglund G. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation (2001) 103 1721-1726.
24. Hosomi N., Mizushige K., Ohyama H. et al. Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus. Stroke (2001) 32 1539-1545.
25. Pontremoli R., Viazzi F., Ravera M. et al. Long term effect of nifedipine GITS and lisinopril on subclinical organ damage in patients with essential hypertension. J. Nephrol. (2001) 14 19-26.
26. Simon A., Gariepy J., Moyse D., Levenson J. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. Circulation (2001) 103 2949-2954.
27. Stanton A.V., Chapman J.N., Mayet J. et al. Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. Clin. Sci. (Lond) (2001) 101 455-464.
28. Hoogerbrugge N., de Groot E., de Heide L.H. et al. Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands. Neth. J. Med. (2002) 60 354-361.
29. Ludwig M., Stapff M., Ribeiro A. et al. Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Clin. Ther. (2002) 24 1175-1193.
30. Terpstra W.F., May J.F., Smit A.J., Graeff P.A., Meyboom-de Jong B., Crijns H.J. Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial). J. Hypertens. (2004) 22 1309-1316.
31. Asselbergs F.W., van Roon A.M., Hillege H.L. et al. Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria. Stroke (2005) 36 649-653.
32. Mortsell D., Malmqvist K., Held C., Kahan T. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study. J. Intern. Med. (2007) 261 472-479.
33. Ichihara A., Kaneshiro Y., Sakoda M., Takemitsu T., Itoh H. Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker. J. Cardiovasc. Pharmacol. (2007) 49 161-166.
34. Tropeano A.I., Boutouyrie P., Pannier B. et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension (2006) 48 80-86.
35. Olsen M.H., Wachtell K., Neland K. et al. Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy. Blood Press. (2005) 14 177-183.
36. Bae J.H., Bassenge E., Lim D.M., Synn Y.C., Kim K.Y., Schwemmer M. Effects of lacidipine on vascular responses in patients with coronary artery disease. Int. J. Cardiol. (2005) 101 377-383.
37. Uchiyama-Tanaka Y., Mori Y., Kishimoto N. et al. Comparison of the effects of quinapril and losartan on carotid artery intima-media thickness in patients with mild-to-moderate arterial hypertension. Kidney Blood Press. Res. (2005) 28 111-116.
38. Zanchetti A., Crepaldi G., Bond M.G. et al. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS - a randomized double-blind trial. Stroke (2004) 35 2807-2812.
39. Stumpe K.O., Agabiti-Rosei E., Zielinski T. et al. Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study. Ther. Adv. Cardiovasc. Dis. (2007) 1 97-106.
40. Napoli C., Bruzzese G., Ignarro L.J. et al. Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension. Am. Heart J. (2008) 156 1154.e1-1154.e8.
41. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 315 629-634.
42. Follmann D., Elliott P., Suh I., Cutler J. Variance imputation for overviews of clinical trials with continuous response. J. Clin. Epidemiol. (1992) 45 769-773.
43. Wang J.G., Staessen J.A., Li Y. et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke (2006) 37 1933-1940.
44. Suurkula M., Agewall S., Fagerberg B., Wendelhag I., Widgren B., Wikstrand J. Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) Group. Arterioscler. Thromb. (1994) 14 1297-1304.
45. Gariepy J., Simon A., Chironi G., Moyse D., Levenson J. Large artery wall thickening and its determinants under antihypertensive treatment: the IMT-INSIGHT study. J. Hypertens. (2004) 22 137-143.
46. Pitt B., Byington R.P., Furberg C.D. et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation (2000) 102 1503-1510.
47. Stumpe K.O., Ludwig M., Heagerty A.M. et al. Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT. Am. J. Cardiol. (1995) 76 50E-54E.
48. Crouse J.R. 3rd, Thompson C.J. An evaluation of methods for imaging and quantifying coronary and carotid lumen stenosis and atherosclerosis. Circulation (1993) 3(Suppl) II17-II33.
49. Hernandez R.H., Armas-Hernandez M.J., Velasco M., Israili Z.H., Armas-Padilla M.C. Calcium antagonists and atherosclerosis protection in hypertension. Am. J. Ther. (2003) 10 409-414.
50. Kato H., Suzuki H., Tajima S. et al. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J. Hypertens. (1991) 9 17-22.
51. Kubo A., Fukuda N., Soma M., Izumi Y., Kanmatsuse K. Inhibitory effect of an angiotensin II type 1 receptor antagonist on growth of vascular smooth muscle cells from spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. (1996) 27 58-63.
52. Morishita R., Gibbons G.H., Ellison K.E. et al. Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J. Clin. Invest. (1994) 94 978-984.
53. Patel M.K., Betteridge L.J., Hughes A.D. et al. Effect of angiotension II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells. J. Hypertens. (1996) 14 341-347.
54. Prescott M.F., Webb R.L., Reidy M.A. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am. J. Pathol. (1991) 139 1291-1296.
55. Chobanian A.V., Haudenschild C.C., Nickerson C., Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension (1990) 15 327-331.
56. Lonn E.M., Yusuf S., Jha P. et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation (1994) 90 2056-2069.
57. Lacy P.S., O'Brien D.G., Stanley A.G., Dewar M.M., Swales P.P., Williams B. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J. Hypertens. (2004) 22 1937-1944.